Join Us

When Cancer Grows Old Report

When Cancer Grows Old: Assessing the Socio-economic Burden of Cancer and Ageing and the Policies Required, a new report released in February 2022, examines the growing socioeconomic impact of cancer amid the global mega-trend of aging and makes recommendations for policies needed to more effectively address the growing burden. With an eleven-fold increased risk of cancer for those age 65 and older, the economic impact of cancer is expected to grow in lockstep with population aging, from 1 to 2% of GDP in 2020 to around 3% by 2040.

The report specifically identifies three areas for improvement in National Cancer Control Plans:

  1. insufficient use of geriatric assessments in clinical practice,
  2. lack of geriatric training among oncologists, and
  3. under-representation of older patients in cancer trials.

When Cancer Grows Old: Assessing the Socio-economic Burden of Cancer and Ageing and the Policies Required was created by KPMG and funded by GCOA member Sanofi.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Brazil Must Fight Antibiotic Resistance

The threat posed by antimicrobial resistance is urgent and spares no country - including Brazil. According to The Lancet, 63 deaths per 100,000 are associated with AMR in Brazil and Paraguay, a rate that exceeds the average for Latin America and the Caribbean. AMR-associated deaths in Brazil are second only to cardiovascular diseases and cancers.

In the News

12 Sep 2023

We Missed 100 Million Adult Vaccines – Here’s How We Get Back on Track

Like other pandemics throughout human history, COVID-19 has caused profound changes that are still rippling through our societies, even as people are understandably eager to move on. In fact, these impacts are all the more dangerous when they are largely ignored or effectively invisible. The decline in adult vaccination may be one of the most significant, as a new report finds that ~100 million doses were missed in 2021 and 2022 alone – reversing global progress towards widespread adult immunisation as a new standard of care in a world of more old than young.

In the News

24 Jul 2023

New Analysis Shows Lost Ground on Adult Immunisation During the Pandemic with 100 Million Doses Potentially Missed

New data shared today by GSK, in collaboration with the IQVIA Institute for Human Data Science and the Global Coalition on Aging (GCOA), estimate approximately 100 million fewer doses of some adult vaccines (excluding Covid-19 vaccines) were administered in 2021 and 2022 than anticipated, based on the global vaccination adoption trends observed from 2013 to 2020, compounding already low adoption rates pre-pandemic.

Press Releases

19 Jul 2023

Going Beyond Applause: The Potential of Caregiving to Unlock Job Opportunities of the Future

Early in the COVID-19 pandemic, the role of caregivers – staff and family who provide care for older and dependent people to carry out activities such as eating or moving - catapulted to the front of our collective conscience. The daily applause for front-line care workers showed a high level of recognition for their incredible work and provided insight into how our health systems must change as our society ages. We need to continue to recognise caregivers as essential to our ageing society.

In the News

27 Jun 2023

High-Level Forum on the Silver Economy 2023

Join us for the High-Level Forum on the Silver Economy 2023. Now in its fourth year, the Silver Economy Forum 2023, December 6 and 7, will explore aging at every stage of life, looking at the growing global Silver Economy through a multigenerational lens. Linking to the goals and aspirations of the UN Decade of Healthy Ageing, SEF 2023 will highlight key themes at the intersection of aging at every age, and the Silver Economy.

Events

09 Jun 2023

Global Coalition on Aging Workshop Calls on G7 Countries to Fund Pull Incentives to Spur Antibiotic Innovation

The Global Coalition on Aging, in partnership with JPMA, today announced the release of its workshop report on the AMR crisis facing G7 countries and the world, “The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis.” If strong action is not taken to address AMR, we will lose the antibiotics we need to cure infections, which is likely to outpace cancer as a major cause of death, killing an estimated 10 million by 2050.

Press Releases

10 May 2023

Ready for a new kind of
conversation about aging?

Feel free to contact us with general inquiries.

+1 (212) 332-3946
[email protected]

Keep In The Loop

Get our newsletter delivered straight to your inbox.

© 2023 Global Coalition On Aging, all rights reserved.